Max Russo, PhD
About Max Russo, PhD
Max Russo, PhD, is a Scientist II at MOMA Therapeutics with expertise in cancer research and toxicology, specializing in functional genomics and CRISPR technology. He has held various research positions at prestigious institutions, including the University of Florida, Dana-Farber Cancer Institute, and Harvard Medical School.
Work at MOMA Therapeutics
Max Russo has been employed at MOMA Therapeutics as a Scientist II since 2021. In this role, he contributes to research initiatives focused on advancing therapeutic solutions. His work involves applying his expertise in functional genomics and CRISPR technology to support the company's mission in drug development.
Education and Expertise
Max Russo holds a Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences from the University of Florida, which he completed from 2015 to 2020. He also earned a Bachelor’s Degree in Biology and Economics from Dickinson College between 2011 and 2015. His academic background is complemented by a Postdoctoral Fellowship in Medical Oncology at Harvard Medical School from 2020 to 2021. Russo specializes in cancer research and toxicology, with a focus on functional genomics.
Background
Max Russo's professional journey includes various research positions. He worked as a Graduate Assistant at the University of Florida from 2015 to 2020. Prior to that, he held internships at Bristol-Myers Squibb in 2012, 2013, and 2014, and completed a Peer Network Engagement Internship at Dickinson College in 2012. He also served as a Postdoctoral Research Fellow at Dana-Farber Cancer Institute, Harvard Medical School, and the Broad Institute of MIT and Harvard from 2020 to 2021.
Achievements in Cancer Research
Max Russo has made significant contributions to the field of genomics, particularly through his work with CRISPR technology. His research includes the design, experimentation, and analysis of CRISPR applications, which are crucial for advancing understanding and treatment of cancer. His expertise in toxicology further supports his research endeavors in this area.